PLEASANTON, Calif. and WILMINGTON, Mass.—— 10X Genomics and Kapa Biosystems today announced that Kapa’s DNA library preparation reagents have been incorporated into the GemCode Platform, enabling a more streamlined workflow generating high quality sequencing data. The GemCode Platform is a unique molecular barcoding and analysis platform that consists of instrumentation, reagents and software to generate […]
Ann Arbor, MI –– Rubicon Genomics, Inc., a provider of innovative pre-analytical reagent kits to improve the performance of genomic analytical platforms and enable the use of liquid biopsies, today announced that it has completed a $2 million growth capital financing. The financing was led by BroadOak Capital Partners, a life sciences focused merchant bank, […]
Sunnyvale, California — Cell viability assays are critical to a broad spectrum of research areas ranging from understanding the mechanisms of cell death to the development of apoptosis-related therapeutics. The EarlyTox cell viability assay kits have been optimized for highly sensitive and accurate microplate-based detection which provide a complete solution for evaluating cell viability. Tailored […]
BOTHELL, WA — BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade cell and tissue hypothermic storage and cryopreservation freeze media and related cloud hosted biologistics cold chain management app for smart shippers today announced that manufacturing process validation has commenced to support the launch of a new product, […]
LOS OSOS, Calif. — Discovery Life Sciences, Inc., a provider of essential clinical research products and services to the Life Sciences industry announced today that it has launched Magellan – an innovative online ordering platform for ready-to-deliver Human Biospecimens designed for Biopharmaceutical, Biotechnology and Medical Device companies who seek to validate the performance of new […]
LEXINGTON, Ky. — Neogen has introduced an ELISA screening test that offers ultrasensitive detection of synthetic cathinones, including methcathinone, methylone and mephedrone, and their metabolites. These drugs are commonly marketed as “bath salts” or “plant food.” Neogen’s new simple, sensitive Synthetic Cathinones (Methcathinone) ELISA test kit has been validated for use with whole blood, serum […]
LGC is pleased to announce that it has been awarded the role of Coordinator for the new Virtual Food Authenticity Network. This is a Defra initiative to help bring together those involved in food authenticity testing and ensure better collaboration and data sharing between all those with an interest. Ultimately, it will give consumers greater […]
Franklin Lakes, NJ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today an updated sustainability strategy and goals for 2020 as part of the release of its 2014 Sustainability Report. The company’s new goals reflect a broader and more integrated agenda than in past years, recognizing four strategic […]
Uric Acid, the body’s most abundant antioxidant to combat oxidative stress, has emerged as a recognized marker for cardiovascular disease (CVD). Decades of epidemiological and clinical evidence have shown correlation between elevated serum uric acid concentrations and cardiovascular disease risk (1-8), as well as in association with hypertension, diabetes, obesity, preeclampsia, gout, metabolic syndrome and […]
LANSING, Mich. — Neogen Corporation has received approval from the AOAC Research Institute for its new rapid and accurate test to definitively detect Listeria monocytogenes DNA in food and environmental samples. Neogen’s newly approved ANSR® for Listeria monocytogenes (Performance Tested MethodSM certification, No. 061506, from the AOAC Research Institute) detects L. monocytogenes after only 10 […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
